BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34926700)

  • 1. Potential Mechanisms of Triptolide against Diabetic Cardiomyopathy Based on Network Pharmacology Analysis and Molecular Docking.
    Zhu N; Huang B; Zhu L; Wang Y
    J Diabetes Res; 2021; 2021():9944589. PubMed ID: 34926700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of Shexiang Tongxin Dropping Pills in treating diabetic cardiomyopathy based on network pharmacology and animal experiments].
    Bai YL; Cui XY; Yuan YY; Zhang YT; Wang W; Liu TH; Wu Y
    Zhongguo Zhong Yao Za Zhi; 2024 Apr; 49(7):1905-1914. PubMed ID: 38812203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Core Gene Biomarkers in Patients with Diabetic Cardiomyopathy.
    Li N; Wu H; Geng R; Tang Q
    Dis Markers; 2018; 2018():6025061. PubMed ID: 30662576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular targets and mechanisms of
    Wang YJ; Wang YL; Jiang XF; Li JE
    World J Diabetes; 2023 Nov; 14(11):1659-1671. PubMed ID: 38077804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic targets of rosuvastatin on heart failure and associated biological mechanisms: A study of network pharmacology and experimental validation.
    Lian Z; Song JX; Yu SR; Su LN; Cui YX; Li SF; Lee CY; Liang HZ; Chen H
    Eur J Pharmacol; 2021 Mar; 895():173888. PubMed ID: 33493484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the mechanism of diabetic cardiomyopathy treated with Qigui Qiangxin mixture based on UPLC-Q/TOF-MS, network pharmacology and experimental validation.
    Han Q; Li Y; Yu Y; Yuan H; Wang Z; Guo Y; Shi J; Xue Y; Liu X
    Sci Rep; 2024 May; 14(1):12119. PubMed ID: 38802644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell insights: pioneering an integrated atlas of chromatin accessibility and transcriptomic landscapes in diabetic cardiomyopathy.
    Su Q; Huang W; Huang Y; Dai R; Chang C; Li QY; Liu H; Li Z; Zhao Y; Wu Q; Pan DG
    Cardiovasc Diabetol; 2024 Apr; 23(1):139. PubMed ID: 38664790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidating the molecular mechanisms of pterostilbene against cervical cancer through an integrated bioinformatics and network pharmacology approach.
    Li X; Yu D; Wang Q; Chen Y; Jiang H
    Chem Biol Interact; 2024 Jun; 396():111058. PubMed ID: 38761877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unravelling the anti-inflammatory mechanism of Allium cepa: an integration of network pharmacology and molecular docking approaches.
    Omoboyede V; Onile OS; Oyeyemi BF; Aruleba RT; Fadahunsi AI; Oke GA; Onile TA; Ibrahim O; Adekiya TA
    Mol Divers; 2024 Apr; 28(2):727-747. PubMed ID: 36867320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the mechanism of Yixinyin for myocardial infarction by weighted co-expression network and molecular docking.
    Huo M; Ma L; Liu G
    Sci Rep; 2021 Nov; 11(1):22567. PubMed ID: 34799616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network pharmacology and experiment validation investigate the potential mechanism of triptolide in oral squamous cell carcinoma.
    Hao P; Zhang P; Liu Y; Cao Y; Du L; Gao L; Dong Q
    Front Pharmacol; 2023; 14():1302059. PubMed ID: 38259290
    [No Abstract]   [Full Text] [Related]  

  • 12. Exploring shared therapeutic targets in diabetic cardiomyopathy and diabetic foot ulcers through bioinformatics analysis.
    Wu H; Yang Z; Wang J; Bu Y; Wang Y; Xu K; Li J; Yan C; Liu D; Han Y
    Sci Rep; 2024 Jan; 14(1):230. PubMed ID: 38168477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential mechanisms of Shenmai injection against POCD based on network pharmacology and molecular docking.
    Yi H; Zhang M; Miao J; Mu L; Hu C
    Int J Neurosci; 2023 Jan; ():1-12. PubMed ID: 36604848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network Pharmacology-Based Analysis on the Action Mechanism of Oleanolic Acid to Alleviate Osteoporosis.
    Wu Y; Gao LJ; Fan YS; Chen Y; Li Q
    ACS Omega; 2021 Oct; 6(42):28410-28420. PubMed ID: 34723038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triptolide, a Cancer Cell Proliferation Inhibitor, Causes Zebrafish Muscle Defects by Regulating Notch and STAT3 Signaling Pathways.
    Lee B; Park Y; Lee Y; Kwon S; Shim J
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network pharmacology and molecular docking technology for exploring the effect and mechanism of high-dose vitamin c on ferroptosis of tumor cells: A review.
    Qu J; Lu S; Wang B; Wang S; Yang Z; Tang H; He J; Zhao Y; Wang X; Liu X; Rao B
    Medicine (Baltimore); 2024 May; 103(20):e38189. PubMed ID: 38758839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Efficacy and Underlying Pathway Mechanisms of ShiDuGao Treatment for Anus Eczema Based on GEO Datasets and Network Pharmacology.
    Wang S; Xiao W; He A; Jia J; Liu G
    J Vis Exp; 2024 Jan; (203):. PubMed ID: 38284541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression Profile of Inflammation Response Genes and Potential Regulatory Mechanisms in Dilated Cardiomyopathy.
    Liang L; Sun J; Teng T; Chen L; Li Z; Zhang Z; Gao Y; Zhang W
    Oxid Med Cell Longev; 2022; 2022():1051652. PubMed ID: 36035223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A network pharmacology study on mechanism of resveratrol in treating preeclampsia
    Shi J; Wang J; Jia N; Sun Q
    Front Endocrinol (Lausanne); 2022; 13():1044775. PubMed ID: 36686428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revealing the therapeutic targets and molecular mechanisms of emodin-treated coronavirus disease 2019 via a systematic study of network pharmacology.
    Du HX; Zhu JQ; Chen J; Zhou HF; Yang JH; Wan HT
    Aging (Albany NY); 2021 Jun; 13(11):14571-14589. PubMed ID: 34088885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.